BI 836858 Dose Escalation in Patients With Refractory or Relapsed Acute Myeloid Leukemia and in Patients With AML in Complete Remission With High Risk to Relapse
Clinical trial NCT01690624 · COMPLETED
Trial details
- NCT number
- NCT01690624
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-13
- Primary completion
- 2018-05-21
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.